Agohob, Nakia .
HRN: 22-24-33 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/25/2023
11/01/2023
IV
70mg
TID
TC Amoebiasis
Checking Final Appropriateness
10/26/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/26/2023
11/01/2023
ORAL
1.9ml
TID
AGE
Checking Final Appropriateness